Metastases To Bone
17 drugs10,164 FAERS reportsMedDRA PT
GET
/api/v1/reaction/metastases-to-boneReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Metastases To Bone (17)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Dextran 40811%
- 2Fulvestrant2,0896.5%
- 3Ribociclib1,6945.5%
- 4Goserelin6865.2%
- 5Radium3244.6%
- 6Exemestane9134.3%
- 7Letrozole2,3193.8%
- 8Cabazitaxel1283.7%
- 9Vinorelbine2523.7%
- 10Flutamide363.7%
- 11Tamoxifen1793.2%
- 12Anastrozole1,0552.9%
- 13Darolutamide1252.4%
- 14Toremifene102.4%
- 15Gefitinib1802.0%
- 16Tetraxetan830.7%
- 17Vipivotide Tetraxetan830.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Metastases To Liver6 shared · 0.30
- Prostate Cancer6 shared · 0.30
- Prostatic Specific Antigen Increased7 shared · 0.27
- Hormone-refractory Prostate Cancer4 shared · 0.24
- Breast Cancer Metastatic5 shared · 0.20
- Prostate Cancer Metastatic3 shared · 0.16
- Breast Cancer4 shared · 0.13
- Sars-cov-2 Test Positive2 shared · 0.11
- Malignant Neoplasm Progression14 shared · 0.09
- Osteonecrosis Of Jaw2 shared · 0.09
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.